Three new life sciences firms have been created by former Pfizer staff \- and are now up and running at their old employer’s ...
We recently compiled a list of the 8 Best Wide Moat Stocks to Buy According to Analysts. In this article, we are going to ...
Pfizer's stock underperformed its healthcare peers since PFE topped out in late July 2024. Click here to find out why I ...
Pharmaceutical giant Pfizer ( PFE 2.73%) stands out in this context. The company currently offers a mouthwatering 5.7% ...
Pfizer is trying to increase doctor awareness of and testing for a rare lung cancer mutation to help boost use of its drug ...
A drug that could reduce the risk of death in cancer patients is showing good promise during its second phase of clinical ...
Jefferies analyst Akash Tewari maintained a Buy rating on Pfizer (PFE – Research Report) today and set a price target of $35.00. The ...
Financial giants have made a conspicuous bearish move on Pfizer. Our analysis of options history for Pfizer PFE revealed ...
Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback